225 related articles for article (PubMed ID: 19502010)
1. Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.
Miller CL; Murakami P; Ruczinski I; Ross RG; Sinkus M; Sullivan B; Leonard S
Schizophr Res; 2009 Sep; 113(2-3):259-67. PubMed ID: 19502010
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
3. The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia.
Miller CL; Dulay JR
Brain Res Bull; 2008 Sep; 77(1):33-41. PubMed ID: 18639743
[TBL] [Abstract][Full Text] [Related]
4. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
[TBL] [Abstract][Full Text] [Related]
5. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
[TBL] [Abstract][Full Text] [Related]
6. Replication study and meta-analysis in European samples supports association of the 3p21.1 locus with bipolar disorder.
Vassos E; Steinberg S; Cichon S; Breen G; Sigurdsson E; Andreassen OA; Djurovic S; Morken G; Grigoroiu-Serbanescu M; Diaconu CC; Czerski PM; Hauser J; Babadjanova G; Abramova LI; Mühleisen TW; Nöthen MM; Rietschel M; McGuffin P; St Clair D; Gustafsson O; Melle I; Pietiläinen OP; Ruggeri M; Tosato S; Werge T; Ophoff RA; ; Rujescu D; Børglum AD; Mors O; Mortensen PB; Demontis D; Hollegaard MV; van Winkel R; Kenis G; De Hert M; Réthelyi JM; Bitter I; Rubino IA; Golimbet V; Kiemeney LA; van den Berg LH; Franke B; Jönsson EG; Farmer A; Stefansson H; Stefansson K; Collier DA
Biol Psychiatry; 2012 Oct; 72(8):645-50. PubMed ID: 22560537
[TBL] [Abstract][Full Text] [Related]
7. The kynurenine pathway in schizophrenia and bipolar disorder.
Erhardt S; Schwieler L; Imbeault S; Engberg G
Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
[TBL] [Abstract][Full Text] [Related]
8. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.
Pae CU; Yu HS; Amann D; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Patkar AA; Lerer B
J Psychiatr Res; 2008 Jan; 42(1):35-40. PubMed ID: 17097106
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population.
Dmitrzak-Weglarz M; Rybakowski JK; Slopien A; Czerski PM; Leszczynska-Rodziewicz A; Kapelski P; Kaczmarkiewicz-Fass M; Hauser J
Neuropsychobiology; 2006; 53(1):46-50. PubMed ID: 16397404
[TBL] [Abstract][Full Text] [Related]
10. Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706.
Tao R; Cousijn H; Jaffe AE; Burnet PW; Edwards F; Eastwood SL; Shin JH; Lane TA; Walker MA; Maher BJ; Weinberger DR; Harrison PJ; Hyde TM; Kleinman JE
JAMA Psychiatry; 2014 Oct; 71(10):1112-20. PubMed ID: 25162540
[TBL] [Abstract][Full Text] [Related]
11. The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes.
Claes S; Myint AM; Domschke K; Del-Favero J; Entrich K; Engelborghs S; De Deyn P; Mueller N; Baune B; Rothermundt M
Psychiatry Res; 2011 Aug; 188(3):355-60. PubMed ID: 21492941
[TBL] [Abstract][Full Text] [Related]
12. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
Williams NM; Green EK; Macgregor S; Dwyer S; Norton N; Williams H; Raybould R; Grozeva D; Hamshere M; Zammit S; Jones L; Cardno A; Kirov G; Jones I; O'Donovan MC; Owen MJ; Craddock N
Arch Gen Psychiatry; 2006 Apr; 63(4):366-73. PubMed ID: 16585465
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder.
Williams HJ; Norton N; Dwyer S; Moskvina V; Nikolov I; Carroll L; Georgieva L; Williams NM; Morris DW; Quinn EM; Giegling I; Ikeda M; Wood J; Lencz T; Hultman C; Lichtenstein P; Thiselton D; Maher BS; ; Malhotra AK; Riley B; Kendler KS; Gill M; Sullivan P; Sklar P; Purcell S; Nimgaonkar VL; Kirov G; Holmans P; Corvin A; Rujescu D; Craddock N; Owen MJ; O'Donovan MC
Mol Psychiatry; 2011 Apr; 16(4):429-41. PubMed ID: 20368704
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions.
Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H
Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391
[TBL] [Abstract][Full Text] [Related]
15. The FEZ1 gene shows no association to schizophrenia in Caucasian or African American populations.
Hodgkinson CA; Goldman D; Ducci F; DeRosse P; Caycedo DA; Newman ER; Kane JM; Roy A; Malhotra AK
Neuropsychopharmacology; 2007 Jan; 32(1):190-6. PubMed ID: 16936715
[TBL] [Abstract][Full Text] [Related]
16. A Loss-of-Function Variant in a Minor Isoform of ANK3 Protects Against Bipolar Disorder and Schizophrenia.
Hughes T; Hansson L; Sønderby IE; Athanasiu L; Zuber V; Tesli M; Song J; Hultman CM; Bergen SE; Landén M; Melle I; Andreassen OA; Djurovic S
Biol Psychiatry; 2016 Aug; 80(4):323-330. PubMed ID: 26682468
[TBL] [Abstract][Full Text] [Related]
17. Association between ST8SIA2 and the Risk of Schizophrenia and Bipolar I Disorder across Diagnostic Boundaries.
Yang SY; Huh IS; Baek JH; Cho EY; Choi MJ; Ryu S; Kim JS; Park T; Ha K; Hong KS
PLoS One; 2015; 10(9):e0139413. PubMed ID: 26418860
[TBL] [Abstract][Full Text] [Related]
18. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia.
Fatemi SH; King DP; Reutiman TJ; Folsom TD; Laurence JA; Lee S; Fan YT; Paciga SA; Conti M; Menniti FS
Schizophr Res; 2008 Apr; 101(1-3):36-49. PubMed ID: 18394866
[TBL] [Abstract][Full Text] [Related]
19. A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus.
Li M; Jaffe AE; Straub RE; Tao R; Shin JH; Wang Y; Chen Q; Li C; Jia Y; Ohi K; Maher BJ; Brandon NJ; Cross A; Chenoweth JG; Hoeppner DJ; Wei H; Hyde TM; McKay R; Kleinman JE; Weinberger DR
Nat Med; 2016 Jun; 22(6):649-56. PubMed ID: 27158905
[TBL] [Abstract][Full Text] [Related]
20. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.
Thiselton DL; Vladimirov VI; Kuo PH; McClay J; Wormley B; Fanous A; O'Neill FA; Walsh D; Van den Oord EJ; Kendler KS; Riley BP
Biol Psychiatry; 2008 Mar; 63(5):449-57. PubMed ID: 17825267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
